A detailed abstract will be added soon.

A detailed abstract will be added soon.

Von Siemens highlights shares his experience and learnings on how to become a global top player, the mindset for "big deals" and how it can make or break a company's success. Through his experiences, von Siemens provides valuable insights into the challenges and opportunities that come with being an innovator on a global scale in the healthtech industry.Overall, von Siemens' keynote speech is a must-see for anyone interested in entrepreneurship, investing, and scaling a business in the healthtech industry. His story is an inspiration for those looking to make a meaningful impact in the world of healthcare.

A detailed abstract will be added soon.

A detailed abstract will be added soon.

A detailed abstract will be added soon.

This award has been created to acknowledge and honor those who dare to venture into the unknown, face adversity with courage, and persist with optimism even when the odds seem insurmountable. They are the boundary-pushers, the change-makers, the ones who, despite everything, refuse to give up.

A detailed abstract will be added soon.

A detailed abstract will be added soon.

A detailed abstract will be added soon.

A detailed abstract will be added soon.

A detailed abstract will be added soon.

A detailed abstract will be added soon.

A detailed abstract will be added soon.

A detailed abstract will be added soon.

A detailed abstract will be added soon.

A detailed abstract will be added soon.

A detailed abstract will be added soon.

A panel with successful operators who share different strategies and challenges on scaling DH in Europe, from B2B provider sales, to B2C2B

While it’s true that increased interest in digital health has cooled off, health tech startups remain a focus for investors – even despite the fact that the dynamics of the market have shifted. Let’s have a look at investors that are standing behind the best deals in health tech and what we should expect in 2023

The world of medtech is transforming patient care, but also creating new risks to sensitive data. Join me to explore the importance of data protection and how medtech companies can stay ahead of the curve to ensure patient privacy and trust.

The speed at which software is shipped has a massive impact on its quality. That's very difficult if you are CE-marked (most healthcare applications are). In this session, I'd like to help educate and answer any questions related to how quickly one can go while being regulated.

The regulatory requirements that medical device manufacturers such as startups must fulfill are overwhelming: Quality systems, risk management systems, post-market surveillance, clinical evaluations (to name just a few) are the scope of continuous audits and reviews by authorities and notified bodies. Most companies already fail with applying for approval / certification. Professor Christian Johner, founder of the Johner Institute, and his team know all these traps and means to avoid them. Christian shares in this masterclass the step-by-step process how to successfully navigate this complex regulatory system, to avoid costly problems and delays in the approval processes and to get the products in the market fast and safely.

Medicine needs digitalisation, but even more so it needs a fundamental paradigm shift. Currently, we hardly understand any disease. That’s why we name diseases only by a symptom in an organ and therapeutically can only alleviate symptoms, which is not only ineffective and imprecise but makes also many diseases chronic. There are many reasons for this innovation roadblock. The biggest conceptual error in Medicine, however, was to split up the human body organ by organ, including organ-specific clinics, specialists, and research disciplines. We believe we can define a disease by looking at one organ; any symptom in a different organ must be a different disease. Really? Rare diseases tell us, no! A big data-driven, holistic approach integrates all medical knowledge back into Systems Medicine to overcome this silo thinking by data science and bioinformatics. It revolutionises how we define diseases. Descriptive disease phenotypes are replaced by mechanistic definitions based on small cellular signalling modules that have become dysfunctional. Upon diagnosis of these in a patient, precise and effective therapeutic intervention is achieved by targeting several points in these networks at low doses, with less side effects and high efficacy. For this, we don’t even need new compounds. In most if not all cases, we can repurpose already registered drugs, obviating the need and costs for classical drug discovery, and speeding up the clinical translation and patent benefit. Thus, how we practice medicine will radically change, from treatment to cure and ideally prevention.

A detailed abstract will be added soon.

Expanding into the U.S. market presents both opportunities and challenges for European healthcare companies. Understanding the unique dynamics of the U.S. healthcare system is crucial, from complex regulatory frameworks to reimbursement models.

Data based solutions have already evidently shown massive impact in daily patient care. Additionally providers also need to uncover sustainable monetization strategies in health systems that are usually changing very slowly. Therefore, this masterclass presents an exemplary process using an algorithm to bust business model myths while unlocking new value pools.

In the rapidly evolving landscape of digital health, achieving successful sales poses numerous challenges that demand careful navigation. This talk delves into the realm of business-to-business (B2B) software sales within the hospital and private/ambulatory sectors. Wieland who has founded two companies in this field (Planerio and Smart Reporting), brings forth his wealth of experience. He successfully exited one of these ventures in 2021. The presentation addresses the distinct hurdles encountered during the journey to achieving scalable and profitable sales. Attendees of this talk will gain a deeper understanding of the intricacies involved in B2B software sales within the digital health domain and will leave equipped with valuable insights to help them overcome challenges and drive sales growth in their own ventures.